Leuko
About Leuko
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: SBIR Phase IIB Grant T: - FT: SBIR Phase IIB Grant |
A: 4500000 MR: - FA: $4.5 million FAN: 4500000 |
D: 2024-07-23 FD: 2024-07-23 |
1 investors |
Growth Metrics
Team & Leadership
Carlos Castro Gonzalez
Chief Executive Officer
Ian Butterworth
Chief Technology Officer
Aurelien Bourquard
Chief Data Scientist
Alvaro Sanchez-Ferro
Chief Medical Officer
Alberto Pablo Trinidad
Machine Learning Engineer
Michael Wolf
Principal Product Engineer
Recent News
Leuko Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- leuko.com
- Industries
- Healthcare Technology
- Company Size
- ~260 employees (est.)
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro